Last updated 2026-07-20
- Raised $2M Undisclosed Round, Aug 2013
Portfolio
1
in our dataset
Rounds participated
1
Rounds led
0
Rounds' value
$5.0M
total disclosed, rounds participated
Stages
—
About
Gabriel Capital Management Ltd. is an investment fund that specializes in minority holdings in late-stage companies operating in Israel and other countries. The fund has a demonstrated track record of investing in Israeli startups and companies, particularly in the life sciences sector. It was founded by Gary Leibler, who also founded Shavit Capital Fund. Gabriel Capital Management has invested in companies such as Intec Pharma Ltd., Brainsway Ltd., and Kamada Ltd. They have also been a 10 percent owner in Anchiano Therapeutics Ltd. and Chemomab Therapeutics Ltd.. While the legal entity is an Israeli company, its HQ is in the US, and it has a strong focus on Israeli investments.
Portfolio · 1
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Gabriel Capital Management's primary sector focus?
- Gabriel Capital Management primarily focuses on the Health Tech & Life Sciences sector, with all of its portfolio companies and exits concentrated in this area.
- Can you name a notable portfolio company for Gabriel Capital Management?
- A notable portfolio company for Gabriel Capital Management is Intec Pharma, which develops controlled drug-delivery technology.
- When did Gabriel Capital Management have a significant exit?
- Gabriel Capital Management had an exit in August 2015 when Intec Pharma went public on the TASE.
- What is the geographic focus of Gabriel Capital Management?
- Gabriel Capital Management is headquartered in the United States.
- When was Gabriel Capital Management founded?
- Gabriel Capital Management was created in May 2019, according to startupim data.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Legal name | Gabriel Capital Management Ltd. |
|---|---|
| Founded | 2013-8 |